[작성자:] Ashley Zhu

On April 6th, 3billion announced that it had received accreditation from the California Department of Public Health (CDPH) as a clinical laboratory in the United States. This certification is separate from CLIA (Clinical Laboratory Improvement Amendments) and is managed by the California Department of Public Health under the state of California. 3billion received CLIA certification three months…

3billion announces that for a service fee of $699, it can diagnose over 7,000 rare diseases by examining patients’ genetic data. The company has over 4,000 actual diagnosis results and is expected to exceed 10,000 diagnoses this year. 3billion CEO Changwon Keum said: By adding proprietary, streamlined interpretation software, we can analyze 100,000+ variants in…

3billion won Xcelerate RARE Challenge, a competition using AI(artificial intelligence) to make discoveries for rare disease patients. The competition, from May 31 to July 31, was organized by Global Genes, the world’s largest rare disease organization, in collaboration with pharmaceutical company Roche. One hundred thirty-two people from 24 teams took part in this competition. In the competition,…

CEO Changwon Keum presented 3billion’s AI-based genome interpretation and diagnosis system at the annual meeting of ‘MENA Organization for Rare Diseases’. held in Dubai, UAE, from March 3rd to 5th.  His presentation placed first in the oral presentation competition.

Mexico City, Mexico – 3billion recently visited major hospitals and research institutions in Mexico City to conduct seminars and meetings aimed at fostering collaboration among medical professionals. During the visit, the company held seminars on rare disease genetic testing and diagnosis at the Children’s Hospital of Mexico Federico Gomez and the National Institute of Pediatrics (INP), two of the…

3billion recently once again opened up applications for the End the Diagnostic Odyssey Grant. We are once again excited to announce the physicians and researchers that were selected as winners. It is our hope that with this grant, they can help further the understanding of their respective field of research, and result in helping future generations…

3billion has completed the installation of Illumina’s NGS sequencer, NovaSeq X. NovaSeq X is the subsequent product of NovaSeq 6000, released in 2017. The amount of DNA that can be sequenced at a time is 2.5 times that of previous models, which can produce WGS data for up to 128 patients or WES data for…

In this webinar, with a clinical genetic expert from 3billion and pediatricians from Europe, get insights into the use of genetic testing in pediatrics with examples. What content does the webinar cover?– Real-life diagnosis cases from European partners with exome sequencing– Benefits of genome sequencing in rare disease diagnosis We recommend this webinar to pediatricians…–…

The Korean startup 3billion has officially closed its Series C funding by raising $13 million. They have raised a total of $30 million since its seed round in 2017. The recent Series C round was led by Wells Investment, JW Asset, Magna Investment, Yuanta Investment, Aventures Investment, Korea Investment & Securities, and Kakao Investment. 3billion…

3billion’s WES product, 3B-EXOME, has been upgraded.These enhancements will be effective for all samples arriving after May 1, 2023. What changed? Mitochondrial genome coverageWe have now included the entire mtDNA sequence evenly in our coverage. This enhancement has improved the accuracy of analysis for mtDNA variants. Increased RPGR gene coverageWe have complemented the RPGR gene coverage with the ORF15 exon…